Katharine H. Banner-Abbott
Stevenage, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study.
Journal: Annals of the rheumatic diseases
Published: December 18, 2023
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
Journal: Pulmonary pharmacology & therapeutics
Published: February 01, 2019
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
Journal: The European respiratory journal
Published: June 08, 2018
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls.
Journal: International journal of chronic obstructive pulmonary disease
Published: September 24, 2016
Translational models of lung disease.
Journal: Clinical science (London, England : 1979)
Published: October 21, 2014
Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.
Journal: Clinical and experimental immunology
Published: February 01, 2014
Dual PDE3/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases.
Journal: Basic & clinical pharmacology & toxicology
Published: December 02, 2013
Targeting TRP channels in airway disorders.
Journal: Current topics in medicinal chemistry
Published: October 19, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026